AFYX THERAPEUTICS
LIVE

Serial Number

88279875

Owner

Dermtreat A/S

Attorney

Carolyn M. Gouges d'Agincourt

Filing Date

Jan 28, 2019

Add to watchlist:

No watchlists yet
View on USPTO

AFYX THERAPEUTICS Trademark

Serial Number: 88279875 • Registration: 5987801

AFYX THERAPEUTICS is a trademark filed by Dermtreat A/S on January 28, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Dermtreat A/S

Lergravsvej 57, 2. tv
København S 2300 , DK

Entity Type: 99

AFYX THERAPEUTICS A/S (4 trademarks)

LERGRAVSVEJ 57, 2. TV
KØBENHAVN S 2300 , DK

Entity Type: 65

AFYX DEVELOPMENT A/S (3 trademarks)

AGERN ALLE 24
H�RSHOLM 2970 , DK

Entity Type: 65

Trademark Details

Filing Date

January 28, 2019

Registration Date

February 18, 2020

Published for Opposition

August 6, 2019

Goods & Services

Pharmaceuticals for treatment of mucosal diseases; pharmaceutical preparations and substances for treatment of mucosal diseases; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for treating mucous membrane disorders; pharmaceutical preparations, namely, muco adhesive patches for efficient and uniform drug release; medicine for treatment of mucosal diseases; medical preparations and articles for treatment of mucosal diseases; medical preparations and articles, namely, mucous membrane- and skin- adhesive patches for coverage of lesions and/or efficient and uniform drug delivery; patches for treatment of mucosal diseases; adhesive patches for medical purposes, namely for treatment of mucosal diseases; skin patches for the transdermal delivery of pharmaceuticals for use in the treatment of mucosal diseases; mucous membrane patches for the transdermal delivery of pharmaceuticals for use in the treatment of mucosal diseases; transdermal patches for use in the treatment of mucosal diseases; transdermal patches for medical treatment for use in the treatment of mucosal diseases; transmucosal patches for medical treatment of mucosal diseases; dressings, medical; adhesive dressings; dressings for wounds; bandages, medical; adhesive bandages; bandages for skin wounds; bandages for mucous membrane wounds; mucosal surface delivery of pharmaceuticals for use in the treatment of mucosal diseases

Medical services; medical treatment services; medical screening; medical monitoring, testing, inspection and analysis services; medical services relating to the diagnosis and treatment of skin disorders; medical services relating to the diagnosis and treatment of mucous membrane disorders; pharmaceutical compounding services; pharmaceutical advisory services; dermatological services for treating skin conditions; dermatological services for treating mucous membrane conditions; laboratory analysis services relating to the diagnosis and treatment of skin disorders; medical laboratory analysis services provided by medical laboratories relating to the diagnosis and treatment of mucous membrane disorders

Scientific, medical and pharmaceutical research and development services; research and development of pharmaceutical preparations; research and development of pharmaceutical preparations for treating skin disorders; research and development of pharmaceutical preparations for treating mucous membrane disorders; research and development of pharmaceutical preparations, namely, muco adhesive patches for efficient and uniform drug release; research and development of medicines; research and development of medical preparations and articles; research and development of medical preparations and articles, namely, mucous membrane- and skin- adhesive patches for coverage of lesions and/or efficient and uniform drug delivery; medical research and analysis services; biological research; clinical research in the field of treatment of mucosal diseases; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 16, 2025 ASGN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 25, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 25, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 25, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 25, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 25, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 25, 2025 COAR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Dec 6, 2024 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 6, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 6, 2024 REAP
WITHDRAWAL OF ATTORNEY GRANTED
Dec 6, 2024 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Dec 6, 2024 WOAR
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2020 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jan 15, 2020 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 15, 2020 AITU
NOTICE OF ALLOWANCE CANCELLED
Nov 26, 2019 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Nov 26, 2019 D1BR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 16, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 16, 2019 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 1, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 6, 2019 NPUB
PUBLISHED FOR OPPOSITION
Aug 6, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 17, 2019 NONP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 10, 2019 ASGN
ELECTRONIC RECORD REVIEW COMPLETE
Jun 28, 2019 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jun 21, 2019 ERRR
ASSIGNED TO LIE
Jun 19, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 6, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 5, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 5, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 9, 2019 GNRN
NON-FINAL ACTION E-MAILED
Apr 9, 2019 GNRT
NON-FINAL ACTION WRITTEN
Apr 9, 2019 CNRT
ASSIGNED TO EXAMINER
Apr 9, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 20, 2019 NWOS
NEW APPLICATION ENTERED
Jan 31, 2019 NWAP